107 studies (23 from unattributed sources) on BPC-157 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
| Manufacturer | Batches | Avg purity | |
|---|---|---|---|
| Verified Peptides | 32 | 99.46% | View COA → |
| Uther Peptide | 31 | 99.71% | View COA → |
| Qing Li Peptide | 31 | 97.1% | View COA → |
| Hk Peptides | 23 | 99.64% | View COA → |
| Peptide Sciences | 22 | 99.51% | View COA → |
| (unknown) | 21 | 99.61% | View COA → |
| Lilipeptide | 21 | 99.49% | View COA → |
| Nexaph | 20 | 99.49% | View COA → |
Recent certificates: #21703 (99.4%) · #21707 (99.9%) · #21722 (98.3%) · #21735 (99.9%) · #21721 (99.9%) · #21728 (99.9%)
Manufacturers with published third-party certificates of analysis for BPC-157. Open a vendor to see every batch we've verified.
This research provides compelling evidence for BPC 157's potential as a novel, rapid-acting therapeutic agent for life-threatening electrolyte disturbances, conditions that currently pose significant clinical challeng…
The comprehensive chemical characterization of BPC-157 is crucial for understanding its consistent biological effects and its potential as a powerful therapeutic agent. Its ability to promote healing across diverse ti…
This Phase 2 trial represents a significant step towards clinical validation for BPC 157 in human musculoskeletal injury. If successful, it could offer a novel therapeutic approach to accelerate recovery from acute ha…
The completion of this Phase 1 trial represents a crucial step towards understanding the clinical viability of oral BPC-157. Establishing a clear safety profile and pharmacokinetic data for BPC-157 in humans is paramo…
This review underscores the transformative potential of therapeutic peptides to address unmet needs in orthopaedic medicine. By offering targeted biological interventions, peptides could significantly improve patient …
This comprehensive review underscores the broad therapeutic potential of BPC-157 as a single agent capable of both promoting robust tissue regeneration and providing direct pain relief. Its ability to act on multiple …
Free, no account — handy when you're working with BPC-157.